Omega-3 fatty acids, homocysteine, and the increased risk of cardiovascular mortality in major depressive disorder

被引:80
作者
Severus, WE
Littman, AB
Stoll, AL
机构
[1] Univ Hosp Benjamin Franklin, Dept Psychiat, D-14050 Berlin, Germany
[2] McLean Hosp, Psychopharmacol Res Lab, Belmont, MA 02178 USA
[3] Massachusetts Gen Hosp, Behav Med Div Prevent Cardiol, Boston, MA 02114 USA
[4] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA
[5] Harvard Univ, Sch Med, Consolidated Dept Psychiat, Boston, MA USA
关键词
D O I
10.1093/hrp/9.6.280
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Depression Is associated with elevated rates of cardiovascular morbidity and mortality. This elevation seems to be due to a significantly increased risk of coronary artery disease and myocardial infarction and, once the ischemic heart disease is established, sudden cardiac death. Recent data suggest that the increased rates of cardiovascular disease in patients with depression may be the result of one or more still-unrecognized underlying physiological factors that predispose a patient to both depression and cardiovascular disease. Two possibly related factors that may have a causal relation with both depressive disorders and cardiovascular disease are an omega-3 fatty acid deficiency and elevated homocysteine levels. We present the available data connecting cardiovascular disease, depression, omega-3 fatty acids, and homocysteine. In addition, we suggest research strategies and some preliminary treatment recommendations that may reduce the increased risk of cardiovascular mortality in patients with major depressive disorder.
引用
收藏
页码:280 / 293
页数:14
相关论文
共 103 条
[51]  
KAGAN BL, 1990, AM J PSYCHIAT, V147, P591
[52]   ESSENTIAL AND OTHER FATTY-ACIDS IN PLASMA IN SCHIZOPHRENICS AND NORMAL INDIVIDUALS FROM JAPAN [J].
KAIYA, H ;
HORROBIN, DF ;
MANKU, MS ;
FISHER, NM .
BIOLOGICAL PSYCHIATRY, 1991, 30 (04) :357-362
[53]  
Krauss RM, 2000, CIRCULATION, V102, P2284
[54]   Depression as a contributing factor in cerebrovascular disease [J].
Krishnan, KRR .
AMERICAN HEART JOURNAL, 2000, 140 (04) :570-576
[55]  
LADWIG KH, 1991, EUR HEART J, V12, P959
[56]  
Loehrer FMT, 1997, J PHARMACOL EXP THER, V282, P845
[57]   Effects of nortriptyline on depression and glycemic control in diabetes: Results of a double-blind, placebo-controlled trial [J].
Lustman, PJ ;
Griffith, LS ;
Clouse, RE ;
Freedland, KE ;
Eisen, SA ;
Rubin, EH ;
Carney, RM ;
McGill, JB .
PSYCHOSOMATIC MEDICINE, 1997, 59 (03) :241-250
[58]   Fluoxetine for depression in diabetes - A randomized double-blind placebo-controlled trial [J].
Lustman, PJ ;
Freedland, KE ;
Griffith, LS ;
Clouse, RE .
DIABETES CARE, 2000, 23 (05) :618-623
[59]   Lowered ω3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients [J].
Maes, M ;
Christophe, A ;
Delanghe, J ;
Altamura, C ;
Neels, H ;
Meltzer, HY .
PSYCHIATRY RESEARCH, 1999, 85 (03) :275-291
[60]   Lower serum vitamin E concentrations in major depression - Another marker of lowered antioxidant defenses in that illness [J].
Maes, M ;
De Vos, N ;
Pioli, R ;
Demedts, P ;
Wauters, A ;
Neels, H ;
Christophe, A .
JOURNAL OF AFFECTIVE DISORDERS, 2000, 58 (03) :241-246